Funding Received
$78.1 Million in 4 Rounds from 3 Investors
Most Recent Funding
$20 Million Series C on June 21, 2013
Founded:
March, 2007
Headquarters:
Menlo Park, CA
Description:
3-V Biosciences is a biopharmaceutical company developing therapeutics for the treatment of infectious diseases.
Categories:
Biotechnology
Website:
http://www.3vbio.com

Detailed Description

Update

3-V Biosciences is a privately held biopharmaceutical company discovering and developing novel therapeutics for the treatment of infectious diseases.

3-V Biosciences was founded by The Column Group (TCG) and Kleiner Perkins Caulfield & Byers (KPCB) in March 2007. In April 2007, the original laboratory was opened in Zürich, Switzerland in close proximity to the company’s founders at the ETH (Swiss Federal Institute of Technology) and the University of Zürich. Host pathway screening began in November 2007 and continues today.

Current Team (6)

Update

Past Team (2)

Update

Board Members and Advisors (6)

Update

Investors (3)

Update

Offices/Locations (1)

Update
  • Office

    1050 Hamilton Court

    Menlo Park, CA 94025

    USA

Images (1)

Update
  • 99c68b848c3e43fbbeef08fdc5cedc46